Sex
|
|
Female, n (%) |
411 (45.5) |
108 (48.0) |
|
Male, n (%) |
493 (54.5) |
117 (52.0) |
Age, years, median (IQR) |
44 (37-50.25) |
43 (38-50) |
Body mass index, kg/m2, median (IQR) |
23.6 (21.3-25.9) |
22.9 (21.2-26) |
Waist circumference, cm, median (IQR) |
81.75 (74.5-88) |
80.5 (74-87) |
Albumin, g/dL, median (IQR) |
4.6 (4.4-4.8) |
4.6 (4.4-4.8) |
Alkaline phosphatase, IU/L, median (IQR) |
58 (49-69) |
58 (48-69) |
Glutamic-oxaloacetic transaminase, IU/L, median (IQR) |
20 (17-24.25) |
20 (17-25) |
Glutamate pyruvate transaminase, IU/L, median (IQR) |
20 (14-31) |
19 (14-28) |
Total bilirubin, mg/dL, median (IQR) |
0.6 (0.5-0.9) |
0.6 (0.4-0.8) |
γ-Glutamyl transpeptidase, U/L, median (IQR) |
18 (12-27) |
17 (11.55-25) |
Controlled attenuation parameter (CAP) score, dB/m, median (IQR) |
247 (211-284) |
241 (216-282) |
Elastic modulus (E) score, kPa, median (IQR) |
4.2 (3.4-4.9) |
4 (3.3-4.8) |
Blood urea nitrogen, mg/dL, median (IQR) |
12 (10-15) |
12 (10-14) |
Creatinine, mg/dL, median (IQR) |
0.8 (0.6-0.9) |
0.8 (0.6-0.9) |
Estimated glomerular filtration rate (eGFR) using the Modification of Diet in Renal Disease (MDRD) equation, median (IQR) |
90.23 (80.49-104.77) |
91.28 (82.72-107.26) |
Uric acid, mg/dL, median (IQR) |
5.5 (4.5-6.6) |
5.4 (4.3-6.6) |
Systolic blood pressure, mm Hg, median (IQR) |
114 (105-125) |
114 (105-126) |
Diastolic blood pressure, mm Hg, median (IQR) |
73 (67-80) |
72 (66-81) |
Cholesterol, mg/dL, median (IQR) |
189 (165-209) |
185 (168-209) |
Triglycerides, mg/dL, median (IQR) |
90 (65-135.2) |
86 (63-126) |
High-density lipoprotein, mg/dL, median (IQR) |
55(45-67) |
54 (47-66) |
Low-density lipoprotein, mg/dL, median (IQR) |
123 (102-145) |
123 (102-145) |
Hemoglobin A1c, %, median (IQR) |
5.4 (5.2-5.6) |
5.4 (5.2-5.5) |
Glucose AC, mg/dL, median (IQR) |
91 (86-96) |
90 (85-95) |